The University of Southampton
University of Southampton Institutional Repository

Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C

Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C
Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C
Comment on:

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
0016-5085
1525-1528
Arthur, Michael J.P.
d61d056b-6470-4afc-bafb-7a20be9cc413
Arthur, Michael J.P.
d61d056b-6470-4afc-bafb-7a20be9cc413

Arthur, Michael J.P. (2002) Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology, 122 (5), 1525-1528. (doi:10.1053/gast.2002.33367). (PMID:11984538)

Record type: Article

Abstract

Comment on:

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

Full text not available from this repository.

More information

Published date: May 2002
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 362553
URI: http://eprints.soton.ac.uk/id/eprint/362553
ISSN: 0016-5085
PURE UUID: c3f2492d-d0ff-45de-b712-fbfa6b77d946

Catalogue record

Date deposited: 03 Mar 2014 10:11
Last modified: 14 Sep 2021 16:49

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×